Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers

Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers

Lindsey McAlarnen, Kristen Stearns, Denise Uyar Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USACorrespondence: Denise UyarDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Medical College of Wisconsi...

Full description

Bibliographic Details
Main Authors:	McAlarnen L, Stearns K, Uyar D
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-01-01
Series:	The Application of Clinical Genetics
Subjects:	genetic testing genomic testing hereditary breast and ovarian cancer syndrome brca cascade testing next generation sequencing
Online Access:	https://www.dovepress.com/challenges-of-genomic-testing-for-hereditary-breast-and-ovarian-cancer-peer-reviewed-article-TACG

Similar Items

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer
by: Arianna Nicolussi, et al.
Published: (2019-04-01)

Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing
by: Hyunseok P. Kang, et al.
Published: (2016-06-01)

Mutational Landscape for Indian Hereditary Breast and Ovarian Cancer Cohort Suggests Need for Identifying Population Specific Genes and Biomarkers for Screening
by: Mohammed Shaad N. Kadri, et al.
Published: (2021-01-01)

A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome
by: Kardashian Ani, et al.
Published: (2012-04-01)

Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing
by: Konstantinos Agiannitopoulos, et al.
Published: (2023-10-01)

Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
by: Anna Öfverholm, et al.
Published: (2023-08-01)

Prevalence and Clinicopathological Characteristics of Moderate and High-Penetrance Genes in Non-BRCA1/2 Breast Cancer High-Risk Spanish Families
by: Maria Fonfria, et al.
Published: (2021-06-01)

Hereditary ovarian cancer
by: I A Demidova
Published: (2015-09-01)

Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?
by: Jeanna M. McCuaig, et al.
Published: (2022-04-01)

Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer
by: Anna P. Sokolenko, et al.
Published: (2023-02-01)

Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study Protocol
by: Tia L. Kauffman, et al.
Published: (2021-11-01)

Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC)
by: Fatima Zahra El Ansari, et al.
Published: (2020-08-01)

Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis
by: Muhammad Danyal Ahsan, et al.
Published: (2023-12-01)

Development and validation of next generation sequencing based 35-gene hereditary cancer panel
by: Wing Chan, et al.
Published: (2020-04-01)

Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome
by: Rodrigo Vicente, et al.
Published: (2022-09-01)

Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer
by: Andrea Nañez, et al.
Published: (2022-02-01)

Genetic testing for hereditary breast cancer in Poland: 1998–2022
by: Jacek Gronwald, et al.
Published: (2023-06-01)

Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!
by: Hikmat Abdel-Razeq
Published: (2021-06-01)

Pathology of Hereditary Breast and Ovarian Cancer
by: Anjelica Hodgson, et al.
Published: (2020-09-01)

Quantitative Analysis of BRCA1 and BRCA2 Germline Splicing Variants Using a Novel RNA-Massively Parallel Sequencing Assay
by: Suzette Farber-Katz, et al.
Published: (2018-07-01)

Hereditary breast and ovarian cancer in Andalusian families: a genetic population study
by: Bella Pajares, et al.
Published: (2018-06-01)

Identification and Characterization of New <i>Alu</i> Element Insertion in the <i>BRCA1</i> Exon 14 Associated with Hereditary Breast and Ovarian Cancer
by: Ahmed Bouras, et al.
Published: (2021-10-01)

Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary Anemias
by: Roberta Russo, et al.
Published: (2020-12-01)

Pathogenic germline variants in patients with breast cancer: conversations across generations, practices and patients’ attitude
by: Hikmat Abdel-Razeq, et al.
Published: (2023-10-01)

Algorithm of molecular genetic investigation to identify hereditary <i>BRCA</i>-associated breast cancer
by: G. P. Snigireva, et al.
Published: (2019-02-01)

An Overview on Radiation Sensitivity in Hereditary Breast and Ovarian Cancer Syndrome
by: Diana Gonçalves, et al.
Published: (2022-07-01)

Prevalence of the <it>BRCA1 </it>founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
by: Ewald Ingrid P, et al.
Published: (2011-12-01)

Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector
by: Nerina C. van der Merwe, et al.
Published: (2022-12-01)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
by: Ingrid Petroni Ewald, et al.
Published: (2016-06-01)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
by: Ingrid Petroni Ewald, et al.
Published: (2016-06-01)

MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER
by: S. A. Laptiev, et al.
Published: (2018-06-01)

Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario
by: Andreza Amália de Freitas Ribeiro, et al.
Published: (2024-03-01)

Hereditary female cancers: Breast, ovarian, and endometrial
by: J. Morgan Tucker, III, et al.
Published: (2011-12-01)

Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer
by: Abdel-Razeq H, et al.
Published: (2023-01-01)

Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia
by: Dorra Ben Ayed-Guerfali, et al.
Published: (2021-03-01)

The disease sites of female genital cancers of BRCA1/2-associated hereditary breast and ovarian cancer: a retrospective study
by: Takashi Mitamura, et al.
Published: (2021-02-01)

Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature
by: Lindsay Carlsson, et al.
Published: (2022-06-01)

Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
by: Daniele Fanale, et al.
Published: (2021-06-01)

Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report
by: Ying Liu, et al.
Published: (2022-12-01)

<i>BRCA1/2</i> Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome
by: Trong-Nhan N. Le, et al.
Published: (2022-01-01)